Entasis Therapeutics Stock Price - ETTX

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Entasis Therapeutics Holdings Inc ETTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.20 8.4% 2.58 2.34 2.64 2.34 2.38 18:00:07
Bid Price Ask Price Spread Spread % News
2.25 2.81 0.56 19.93% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
226 34,455 $ 2.48 $ 85,348 24,020 1.75 - 9.25
Last Trade Time Type Quantity Stock Price Currency
16:00:00 3,228 $ 2.58 USD

Entasis Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 37.70M 14.61M 14.59M $ 7.00M $ - -3.34 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 0.20%

more financials information »

Entasis Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ETTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.622.702.312.3925,687-0.04-1.53%
1 Month2.722.802.312.6221,868-0.14-5.15%
3 Months5.255.641.752.8931,482-2.67-50.86%
6 Months4.705.641.753.4320,329-2.12-45.11%
1 Year6.249.251.754.5916,638-3.66-58.65%
3 Years13.4513.701.756.9028,857-10.87-80.82%
5 Years13.4513.701.756.9028,857-10.87-80.82%

Entasis Therapeutics Description

Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes Zoliflodacin, ETX0282CPDP, and NBP program.

Your Recent History
Entasis Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.